"Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]." Blood and Lymphatic Cancer: Targets and Therapy, , p. 11
This article refers to: